Buy Biaxin

Biaxin

What is Biaxin?

Biaxin is a brand-name medication that contains the antibiotic clarithromycin as its active ingredient. It is available as oral pills in strengths of 250 mg and 500 mg and belongs to the macrolide class of antibiotics. In the United Kingdom Biaxin is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).

How Biaxin Works in the Body

Clarithromycin interferes with bacterial protein synthesis. It binds to the 50 S subunit of the bacterial ribosome, preventing the translocation step that is essential for creating new proteins. This inhibition stops bacterial growth (bacteriostatic) and, at higher concentrations, can kill susceptible organisms (bactericidal). The drug is absorbed well after oral administration, reaching peak plasma concentrations within 2-3 hours. It is extensively metabolised in the liver, primarily via the cytochrome P450 3A4 (CYP3A4) enzyme, and is excreted in the bile and urine.

Conditions Treated by Biaxin

Biaxin is approved in the UK for the treatment of the following infections, as determined by clinical trials and regulatory review:

• Community-acquired pneumonia caused by susceptible streptococci, Haemophilus influenzae, and atypical organisms.
• Acute bacterial exacerbations of chronic bronchitis.
• Uncomplicated skin and soft-tissue infections (e.g., cellulitis, erysipelas) caused by susceptible bacteria.
• Sinusitis and otitis media when caused by organisms sensitive to clarithromycin.
• Helicobacter pylori eradication regimens (used in combination with other agents).

These indications reflect the antibiotic’s activity against a broad spectrum of Gram-positive and some Gram-negative bacteria, as well as atypical pathogens such as Mycoplasma and Chlamydophila species.

Patient Suitability and Contraindications

Who should consider Biaxin?

• Adults with a confirmed or strongly suspected bacterial infection caused by organisms known to be susceptible to clarithromycin.
• Patients who can swallow pills and have no known allergy to macrolide antibiotics.

Absolute contraindications

• Known hypersensitivity to clarithromycin, other macrolides (e.g., erythromycin, azithromycin), or any of the excipients in the tablet.
• Concurrent use of drugs that are strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) where dose adjustment is not possible.

Relative contraindications

• Severe hepatic impairment (Child-Pugh class C).
• Pregnant or breastfeeding women: clarithromycin is classified as Category D in the UK, indicating potential risk; it should only be used when the benefit outweighs the risk.
• History of prolonged QT interval or other cardiac conduction disorders.

Special populations

• Elderly: Dose adjustments may be needed due to reduced hepatic clearance.
• Renal impairment: No dose change is required for mild to moderate dysfunction, but caution is advised in severe renal failure.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Gastrointestinal upset (nausea, abdominal pain, diarrhoea) - reported in more than 1 % of users.
• Altered taste (metallic or bitter) - usually transient.
• Mild headache.

Serious Adverse Events

• Hepatotoxicity (elevated liver enzymes, jaundice) - rare but requires immediate medical assessment.
• Severe allergic reactions (anaphylaxis, Stevens-Johnson syndrome) - medical emergency.
• Cardiac arrhythmias due to QT prolongation - especially in patients with existing heart disease or electrolyte disturbances.

Drug Interactions

• Major: Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) can increase clarithromycin levels, raising the risk of toxicity.
• Moderate: Drugs that prolong the QT interval (e.g., fluoroquinolones, certain anti-arrhythmics) may have additive cardiac effects.
• Other notable interactions: Warfarin (may increase INR), theophylline (may raise plasma concentrations), and statins metabolised by CYP3A4 (e.g., simvastatin) - monitoring or dose adjustment is recommended.

Food and Lifestyle Interactions

• Clarithromycin can be taken with or without food; however, taking it with a high-fat meal may slightly delay absorption.
• Alcohol does not have a direct interaction, but excessive intake may worsen gastrointestinal side effects and liver stress.
• Caution when operating machinery if dizziness occurs; most patients tolerate the drug well.

How to Take Biaxin

• Standard adult dosing: The usual regimens are 250 mg twice daily for uncomplicated skin infections and 500 mg twice daily for respiratory infections such as pneumonia. The exact dose and duration depend on the infection being treated and should be determined by a prescriber.
• Special populations: For patients with severe liver impairment, the dose may be reduced to 250 mg twice daily regardless of infection type. Dose adjustments in the elderly follow the same principle.
• Administration: Swallow the tablet whole with a full glass of water. Do not crush, chew, or split the pill unless specifically instructed.
• Missed dose: Take the missed dose as soon as remembered unless the next scheduled dose is within a few hours; in that case, skip the missed dose and continue the regular schedule. Do not double the dose.
• Overdose: Symptoms may include severe nausea, vomiting, abdominal pain, and cardiac rhythm disturbances. Seek urgent medical attention; supportive care and activated charcoal are typical emergency measures.
• Discontinuation: For most infections, treatment should be completed to avoid resistance. In certain cases (e.g., H. pylori regimens), a taper is not required, but abrupt cessation without medical advice is discouraged.

Monitoring and Follow-Up

• Liver function tests: Recommended before starting therapy in patients with known liver disease and periodically during prolonged treatment.
• Electrolytes and ECG: May be considered for patients at risk of QT prolongation, especially when combined with other QT-prolonging agents.
• Clinical response: Patients should be re-evaluated within 48-72 hours of initiating therapy to ensure improvement; lack of response may necessitate a change in antibiotic.

Storage and Handling

• Store tablets at room temperature (15-25 °C) in a dry place, protected from light and moisture.
• Keep out of reach of children; use child-proof containers.
• Do not use tablets after the expiry date printed on the packaging. Dispose of unused medication in accordance with local pharmacy take-back programmes.

Medication-Specific Glossary

Macrolide

A class of antibiotics characterised by a large macrocyclic lactone ring; includes clarithromycin, erythromycin, and azithromycin.

QT Prolongation

Extension of the heart’s electrical repolarisation period, which can increase the risk of a potentially life-threatening arrhythmia called torsades de pointes.

CYP3A4

An enzyme in the liver that metabolises many drugs; clarithromycin inhibits this enzyme, leading to possible drug-drug interactions.

Medical Disclaimer

This article provides educational information about Biaxin and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.